BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 17091618)

  • 41. Breast cancer-associated opsoclonus-myoclonus syndrome: a case report.
    Kostoglou A; Vlastos D; Bakalis A; Ghosh D
    World J Surg Oncol; 2021 Nov; 19(1):328. PubMed ID: 34781971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung.
    Alkan A; Cenikli U; Uylaş S; Yılmaz M; Çakır T; Çetinkaya H; Kıran A; Tanrıverdi Ö
    J Oncol Pharm Pract; 2020 Jan; 26(1):209-211. PubMed ID: 30791855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delayed Opsoclonus-Myoclonus Syndrome After Ovarian Teratoma Resection.
    Jones AA; Chen T
    J Neuroophthalmol; 2022 Mar; 42(1):e450-e451. PubMed ID: 34417773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Tate ED; Hoefgen ER; Swan JA; Colliver JA
    Cytokine; 2008 Oct; 44(1):26-32. PubMed ID: 18675552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paraneoplastic opsoclonus-myoclonus-ataxia syndrome revealing dual malignancy.
    Nasri A; Kacem I; Jerdak F; Djebara MB; Mejri N; Sidhom Y; Gargouri A; Gouider R
    Neurol Sci; 2016 Oct; 37(10):1723-5. PubMed ID: 27329274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Paraneoplastic opsoclonus].
    Nielsen HB; Nielsen G; Lühdorf K
    Ugeskr Laeger; 1997 Mar; 159(12):1774-5. PubMed ID: 9092159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung.
    Ridley A; Kennard C; Scholtz CL; Büttner-Ennever JA; Summers B; Turnbull A
    Brain; 1987 Dec; 110 ( Pt 6)():1699-709. PubMed ID: 2827840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of autoantigens in pediatric opsoclonus-myoclonus syndrome.
    Blaes F; Fühlhuber V; Preissner KT
    Expert Rev Clin Immunol; 2007 Nov; 3(6):975-82. PubMed ID: 20477144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 18F-FDG PET/CT Brain Imaging on a Patient With Paraneoplastic Opsoclonus-Myoclonus Syndrome Arising out of a Mature Cystic Teratoma.
    Na CJ; Jeong YJ; Lim ST; Sohn MH; Jeong HJ
    Clin Nucl Med; 2016 Feb; 41(2):e104-6. PubMed ID: 26545025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
    Blaes F; Dharmalingam B
    Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective study of the presentation and management of dancing eye syndrome/opsoclonus-myoclonus syndrome in the United Kingdom.
    Pang KK; de Sousa C; Lang B; Pike MG
    Eur J Paediatr Neurol; 2010 Mar; 14(2):156-61. PubMed ID: 19423368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on opsoclonus-myoclonus syndrome in adults.
    Oh SY; Kim JS; Dieterich M
    J Neurol; 2019 Jun; 266(6):1541-1548. PubMed ID: 30483882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opsoclonus-myoclonus syndrome following influenza a infection.
    Morita A; Ishihara M; Kamei S; Ishikawa H
    Intern Med; 2012; 51(17):2429-31. PubMed ID: 22975562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
    Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
    BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Augmented startle responses in opsoclonus-myoclonus syndrome.
    Yonekawa T; Saito Y; Sakuma H; Sugai K; Shimizu Y; Inagaki M; Sasaki M
    Brain Dev; 2011 Apr; 33(4):335-8. PubMed ID: 20591595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
    Pranzatelli MR; Tate ED; McGee NR
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27097. PubMed ID: 29727049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Treatment of Opsoclonus-Myoclonus Syndrome Secondary to Neuroblastic Tumours-Single-Centre Experience and Literature Review.
    Mizia-Malarz A; Stolpa W; Sobol-Milejska G
    Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32823831
    [No Abstract]   [Full Text] [Related]  

  • 58. The movement disorder of adult opsoclonus.
    Caviness JN; Forsyth PA; Layton DD; McPhee TJ
    Mov Disord; 1995 Jan; 10(1):22-7. PubMed ID: 7885352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dancing eyes, dancing feet: opsoclonus-myoclonus in an 18-month-old child with neuroblastoma.
    Badaki OB; Schapiro ES
    Pediatr Emerg Care; 2007 Dec; 23(12):885-8. PubMed ID: 18091597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.